arrow
E

Ellis Niemantsverdriet

University of Antwerp
H指数:24
被引数:2,427

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting

脑脊液Aβ1-42/Aβ1-40比率可改善与淀粉样蛋白-PET的一致性,以在临床环境中诊断阿尔茨海默氏病

2025-02-0674
OAAI
Brain age as a biomarker for pathological versus healthy ageing - a REMEMBER study
2024-06-141
OAAI
Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis
2022-04-1316
OA
Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers

将阿尔茨海默病病理学与其脑脊液生物标志物相关联

BRAIN
IF11.7
2022-01-1323
OA
Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER Study
2021-09-1413
OAAI
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
2020-11-2231
OAAI
18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET

18F-FDG PET,18F-AV45 PET的早期阶段和递送速率作为阿尔茨海默氏病脑血流的代理: 针对15O-H2O PET的验证

2019-08-0937
OAAI
Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and 18F-FDG-PET imaging

CSF,MRI,淀粉样蛋白和18F-FDG-PET成像与短期认知能力下降和MCI到AD痴呆转化的关联

2019-01-01112
OAAI
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study
2017-03-0329
OAAI